Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies
The burden of liver disease in Europe continues to grow. We aimed to describe the
epidemiology of liver diseases and their risk factors in European countries, identifying public …
epidemiology of liver diseases and their risk factors in European countries, identifying public …
[HTML][HTML] Chronic hepatitis C and liver fibrosis
G Sebastiani, K Gkouvatsos… - World journal of …, 2014 - ncbi.nlm.nih.gov
Chronic infection with hepatitis C virus (HCV) is a leading cause of liver-related morbidity
and mortality worldwide and predisposes to liver fibrosis and end-stage liver complications …
and mortality worldwide and predisposes to liver fibrosis and end-stage liver complications …
[PDF][PDF] Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing …
MG Ghany, TR Morgan… - …, 2020 - Wiley Online Library
HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …
[HTML][HTML] CDC recommendations for hepatitis C screening among adults—United States, 2020
S Schillie - MMWR. Recommendations and Reports, 2020 - cdc.gov
Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …
[图书][B] WHO guidelines on hepatitis B and C testing
World Health Organization - 2017 - apps.who.int
Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
K Gariani, KJ Menzies, D Ryu, CJ Wegner… - …, 2016 - Wiley Online Library
With no approved pharmacological treatment, nonalcoholic fatty liver disease (NAFLD) is
now the most common cause of chronic liver disease in Western countries and its worldwide …
now the most common cause of chronic liver disease in Western countries and its worldwide …
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study …
Background Previous estimates of the burden of HIV, hepatitis B virus (HBV), and hepatitis C
virus (HCV) among people who inject drugs have not included estimates of the burden …
virus (HCV) among people who inject drugs have not included estimates of the burden …
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim… - BMC infectious …, 2013 - Springer
Background Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection is improving but not benefiting individuals unaware to be infected. To inform …
infection is improving but not benefiting individuals unaware to be infected. To inform …
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus
DB Rein, JS Wittenborn, BD Smith… - Clinical infectious …, 2015 - academic.oup.com
Background. New hepatitis C virus (HCV) treatments deliver higher cure rates with fewer
contraindications, increasing demand for treatment and healthcare costs. The cost …
contraindications, increasing demand for treatment and healthcare costs. The cost …
Chronic HCV infection: epidemiological and clinical relevance
S Zaltron, A Spinetti, L Biasi, C Baiguera… - BMC infectious …, 2012 - Springer
Hepatitis C virus (HCV), first recognized as a cause of transfusion-associated acute and
chronic hepatitis in 1989, plays a major role as a cause of chronic liver injury, with potential …
chronic hepatitis in 1989, plays a major role as a cause of chronic liver injury, with potential …